Stoneridge

SRI

Market cap $205M

NOVI, Mich., June 30, 2026 /PRNewswire/ -- Stoneridge, Inc. (NYSE: SRI), a leading supplier of safe, intelligent and efficient electronic technologies for the commercial vehicle and off-highway equipment markets, today announced that the Company has been added to the Russell 2000® Index as part of the 2026 FTSE Russell U.S. Indexes annual reconstitution.

Debut of new ECU technology that enables unified, software-defined vehicle architecture Showcase of European Innovation Truck equipped with advanced integrated vision systems STOCKHOLM, June 25, 2026 /PRNewswire/ -- Stoneridge, Inc., a leading supplier of safe, intelligent and efficient electronic technologies for commercial vehicles, buses, coaches and the off-highway equipment, today announced its participation in IAA Transportation 2026, where the company will showcase major innovations designed to help shape the future of commercial vehicle technology. At the center of the Stoneridge exhibit will be its new EVO ECU platform, a powerful and scalable electronic control unit designed to support the industry's transition toward software-defined vehicles.

TORONTO, ON / ACCESS Newswire / June 18, 2026 / Sparton Resources Inc. (TSXV:SRI) ("Sparton" or the "Company") announced today it has entered into a binding Letter of Intent giving it a 3 year option to acquire a 100% interest in the past producing Morrison Silver Mine, located near Gowganda, Ontario. The Morrison Mine produced over 750,000 ounces of silver at a final average grade of 25 ounces per short ton during intermittent production between 1912 and 1955 (report by L.J.

NEW YORK--(BUSINESS WIRE)--JPMorganChase today announced the expansion of its $1.5 trillion, 10-year Security and Resiliency Initiative (SRI) to Canada. The announcement builds on SRI's recent expansion to Europe and the firm's momentum in Canada, which has nearly doubled franchise revenue and increased headcount by a third over the past five years. First announced in the United States in October, SRI is a $1.5 trillion, 10-year initiative to facilitate, finance and invest in five key verticals.

LONDON--(BUSINESS WIRE)--Ellipses Pharma (“Ellipses”), a global oncology drug development company with a pipeline of innovative programmes, announced today that its partner, Kelun-Biotech, is presenting pivotal trial data for EP0031/A400, for the potential treatment of RET-fusion positive Non-Small Cell Lung Cancer (NSCLC), at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting Chicago, May 29 to June 2. Efficacy and safety of lunbotinib (A400/EP0031), a next-generation selecti.

Stoneridge, Inc. (SRI) Q1 2026 Earnings Call Transcript

Q1 Performance Demonstrates Solid Progress Continued Strong Momentum with Program Awards for MirrorEye ® and Electronic Controls NOVI, Mich., May 7, 2026 /PRNewswire/ -- Stoneridge, Inc. (NYSE: SRI) today announced financial results for the first quarter ended March 31, 2026.

NOVI, Mich., May 4, 2026 /PRNewswire/ -- Stoneridge, Inc. (NYSE: SRI) will webcast its first quarter 2026 earnings conference call live on Thursday, May 7, 2026, at 9:00 a.m.

NOVI, Mich., April 28, 2026 /PRNewswire/ -- Driven by accelerating global demand for advanced vision systems, Stoneridge, Inc. (NYSE: SRI) has achieved significant milestones for its award-winning MirrorEye ® Camera Monitor System (CMS), underscoring the company's strong market momentum and continued innovation in commercial vehicle safety and efficiency.

Stoneridge remains a "Buy" despite recent revenue and profit declines, driven by optimism around MirrorEye and long-term growth prospects. Recent results were weak, with 2025 revenue down 6% and net loss widening, but impairment charges and income taxes drove much of the deterioration. MirrorEye revenue grew 69% year-over-year to $111 million, with management projecting significant incremental growth and new business awards totaling $830 million.